Welcome to LookChem.com Sign In|Join Free
  • or
2-(2,4-dinitrophenoxy)bromoethane, also known as DNPB, is a chemical compound with the molecular formula C8H6BrNO5. It is a yellow crystalline solid that is soluble in water and various organic solvents. DNPB is primarily used as a chemical intermediate in the synthesis of pharmaceuticals, agrochemicals, and other specialty chemicals. It is also known for its potential use as a reagent in the detection of certain enzymes and in the preparation of other chemical compounds. Due to its reactivity and potential health risks, DNPB is handled with caution in industrial settings, and appropriate safety measures are taken to minimize exposure.

58910-35-3

Post Buying Request

58910-35-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

58910-35-3 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 58910-35-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,8,9,1 and 0 respectively; the second part has 2 digits, 3 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 58910-35:
(7*5)+(6*8)+(5*9)+(4*1)+(3*0)+(2*3)+(1*5)=143
143 % 10 = 3
So 58910-35-3 is a valid CAS Registry Number.

58910-35-3Relevant academic research and scientific papers

Synthesis, biological activity evaluation and molecular modeling study on the new isoconessimine derivatives as acetylcholinesterase inhibitors

Jin, Guofei,Yang, Zhongduo,Xue, Weiwei,Sheng, Jie,Shi, Yin,Yao, Xiaojun

, p. 1228 - 1233 (2013)

New isoconessimine derivatives were synthesized from conessine (1) and evaluated as acetylcholinesterase (AChE) inhibitors. The derivatives were prepared via two reaction steps, N-demethylation and nucleophilic substitution. All of the synthesized derivatives exhibited more potential anti- acetylcholinesterase activities than conessine (1) (IC50=16 μmol·L-1) and isoconessimine (2) (IC50>300 μmol·L-1). Compound 7b (3β-[methyl-[2-(4-nitrophenoxy) ethyl]amino]con-5-enine) showed the most potent inhibitory activity with an IC50 of 110 nmol/L which is close to that of reference compound huperzine A (IC50=70 nmol/L). The mode of AChE inhibition by 7b was reversible and non-competitive. In addition, molecular modeling was performed to explore the binding mode of inhibitor 7b at the active site of AChE and the results showed that 7b could be docked into the acetylcholinesterase active site and compound 7b had hydrophobic interactions with Trp279 and Leu282. A series of 3-N-aryloxyethyl substitutional isoconessimine derivatives were synthesized and evaluated as acetylcholinesterase (AChE) inhibitors. All of the synthesized derivatives exhibited potential anti-acetylcholinesterase activities with IC50 values at micromolar to sub-micromolar range. 7b showed the most potent inhibitory activity with an IC50of 110 nmol/L. The molecular docking results showed that 7b can be well docked into the active site of acetylcholinesterase. Copyright

Choline derivatives brominated three ethyl-2 - (2,4-dinitrophenoxy) ethyl ammonium preparation method

-

Paragraph 0018; 0023; 0024, (2016/10/07)

The invention discloses a preparation method of a choline derivative, namely, bromotriethyl-2-(2,4-dinitrophenoxyl)ethylammonium. The invention discloses a preparation method of a novel choline derivative. The preparation method comprises the following st

Synthesis and biological activity of KCB-328 and its analogues: Novel class III antiarrhythmic agents with little reverse frequency dependence

Kim, Dong-Ick,Kim, Hak-Yeop,Kwon, Lae-Sung,Park, Sung-Dae,Jeon, Gee-Ho,Jung, Kyung-Yun,Min, Jae-Ki,Nam, Woong-Hyun,Lee, Kiho,Chung, You-Sup,Tanabe, Shigeru,Kozono, Toshiro

, p. 85 - 90 (2007/10/03)

A series of 3,4-dimethoxyphenethylamine derivatives was prepared, and their prolongation effects on effective refractory period of contractile response (ERPc) and action potential duration (APD) in isolated guinea-pig papillary muscles at 1 Hz and 3 Hz were examined. SAR studies led to the identification of KCB-328 (51) which is a novel class III antiarrhythmic agent with little reverse frequency dependence.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 58910-35-3